Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Lancet Digit Health. 2022 Jun;4(6):e426–e435. doi: 10.1016/S2589-7500(22)00041-3

Table 3:

Bias report for temporal validation dataset (year 2020)

N Substance misuse prevalence False-discovery rate (95% CI) False-positive rate (95% CI) False-omission rate (95% CI) False-negative rate (95% CI)
All encounters 16917 1023 0·25 (0·23–0·29) 0·02 (0·02–0·02) 0·01 (0·01–0·01) 0·18 (0·15–0·20)
Age group, years
 18–44 5336 433 0·19 (0·16–0·23) 0·02 (0·01–0·02) 0·01 (0·01–0·02) 0·16 (0·13–0·20)
 ≥45 11 581 590 0·30 (0·26–0·33) 0·02 (0·02–0·02) 0·01 (0·01–0·01) 0·18 (0·15–0·21)
Sex
 Female 9944 315 0·29 (0·24–0·34) 0·01 (0·01–0·01) 0·01 (0·01–0·01) 0·22 (0·17–0·27)
 Male 6973 708 0·25 (0·22–0·28) 0·03 (0·03–0·04) 0·02 (0·02–0·02) 0·16 (0·13–0·19)
Race and ethnicity
 Non-Hispanic Black 6190 445 0·29 (0·26–0·34) 0·03 (0·02–0·03) 0·03 (0·02–0·03) 0·18 (0·15–0·22)
 Non-Hispanic White 6156 353 0·22 (0·18–0·26) 0·01 (0·01–0·02) 0·01 (0·01–0·02) 0·19 (0·15–0·23)
 Hispanic 3329 159 0·20 (0·14–0·26) 0·01 (0·01–0·02) 0·01 (0·01–0·02) 0·15 (0·09–0·21)
*Mixed 1242 66 0·32 (0·22–0·43) 0·02 (0·02–0·03) 0·02 (0·02–0·03) 0·14 (0·06–0·24)

Substance misuse prevalence represents any occurrence of alcohol misuse, opioid misuse, or non-opioid drug misuse. The referent labels and predicted labels for any type of substance misuse were used to calculate the number of false positives (FP), true positives (TP), false negatives (FN), and true negatives (TN). Bias assessment metrics included: false-discovery rate (FP/[FP+TP]); false-positive rate (FP/[FP+TN]); false-omission rate (FN/[FN+TN]); and false-negative rate (FN/[FN+TP]).

*

Mixed=Asian, Native-American, or Pacific Islander, other, or refused to answer or answer unknown.